Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
Liver International : Official Journal of the International Association for the Study of the Liver|June 15, 2018
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?Loreta A Kondili, Sarah Robbins, Sarah Blach, et al.
Autoimmunity Reviews|February 10, 2011
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patientsMaurizio Pietrogrande, Salvatore De Vita, Anna Linda Zignego, et al.
Hepatology (Baltimore, Md.)|July 26, 2017
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohortLoreta A Kondili, Federica Romano, Francesca Romana Rolli, et al.
Journal of Hepatology|November 26, 2018
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D'Ambrosio, Luisa Pasulo, Massimo Puoti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2019
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life studyRoberta D'Ambrosio, Luisa Pasulo, Alessia Giorgini, et al.
The New England Journal of Medicine|January 25, 2018
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 InfectionStefan Zeuzem, Graham R Foster, Stanley Wang, et al.
Infection Prevention in Practice|December 18, 2024
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus modelAgnese Comelli, Camilla Genovese, Giulia Renisi, et al.
JAMA Network Open|November 29, 2021
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical TrialFrancesco Menichetti, Patrizia Popoli, Maria Puopolo, et al.
Gut|July 20, 2021
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort studyLuca Saverio Belli, Christophe Duvoux, Paolo Angelo Cortesi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapiesVelia C Di Maio, Valeria Cento, Ilaria Lenci, et al.
Pageof 24